Who owns Abbvie?
- CUSIP Number: 00287Y959
Tip: Access positions for across all investors
Analyze quarterly positions in Abbvie with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abbvie stock
Who bought or sold Abbvie this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 752k | $137M | 23% | Mar 2024 |
|
| Jpmorgan Chase & Co | 460k | $84M | 118% | Mar 2024 |
|
| Simplex Trading | 356k | $65M | 7% | Mar 2024 |
|
| IMC-Chicago | 254k | $46M | 5% | Mar 2024 |
|
| SG Americas Securities | 190k | $292k | -25% | Mar 2024 |
|
| Allianz Asset Management | 155k | $24M | -41% | Dec 2023 |
|
| Group One Trading | 60k | $11M | 5% | Mar 2024 |
|
| Gladius Capital Management | 22k | $3.4M | -65% | Dec 2023 |
|
Who sold out of Abbvie?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Twin Tree Management | Dec 2023 | 377k | $58M |